March 20, 2023 5:11 PM
Psychedelics Reform Update: 22 States Where Proposals Are Being Discussed & Local Moves Considered
In the first months of 2023, state-level psyche ...
March 19, 2023 9:01 AM
In light of the latest news regarding the DEA’s telehealth regulations and the closing of two renowned ketamine clinics ...
March 17, 2023 3:38 PM
Early-stage psychedelics manufacturing company Lucy Scientific Discovery Inc. (NASDAQ: LSDI) partnered with specialized firm Pramantha Group to o ...
March 17, 2023 11:30 AM
Israeli biotech Clearmind Medicine Inc. (NASDAQ: CMND) has submitted an Investigational New Drug (IND) application with the FDA towards approval to co ...
March 17, 2023 9:49 AM
Australia-based biopharma giant Incannex Healthcare Ltd. (NASDAQ: IXHL) has plans to commercialize its psychedelic-assisted psychotherapy business thr ...
March 16, 2023 4:03 PM
Irwin Naturals Inc. (OTC: IWINF) has terminated the non-binding amended and restated letter of intent (LOI) for a business combination with medical re ...
March 16, 2023 9:36 AM
(Part one of three.)
In view of the latest news regarding the DEA’s telehealth regulations and the closing of two renowned ketamine clinics ...
March 15, 2023 4:54 PM
Three companies have provided updates on their efforts to assess different psychedelics for treating a widely varied set of conditions.
Filament To Be ...
March 15, 2023 1:39 PM
Closely following the announcement of what's to become of the new regulations for telehealth, including ketamine therapy, several of in- ...
March 14, 2023 6:34 PM
FSD Pharma Inc. (NASDAQ: HUGE) has renewed a service agreement with shareholder intelligence services provider ShareIntel LLC to assist in ongoing inv ...
March 14, 2023 6:05 PM
COMPASS Pathways' (NASDAQ: CMPS) Phase 2b study of synthetic psilocybin COMP360 paired with psychological support for Treatment-Resistant Dep ...
March 14, 2023 4:23 PM
Falcon Rappaport & Berkman LLP (FRB)’s Cannabis & Psychedelics Practice Group joins several law firms that offer cannabis ...
March 14, 2023 4:14 PM
Biopharma company Enveric Biosciences (NASDAQ: ENVB) has shared new findings involving the first-ever isolation of a specific enzyme from the cane toa ...
March 14, 2023 2:24 PM
Clinical-stage biopharma company Reunion Neuroscience Inc. (NASDAQ: REUN) filed a lawsuit against drug discovery business Mindset Pharma Inc. (OT ...
March 13, 2023 5:13 PM
Major Depressive Disorder: Small Pharma’s Phase 2 DMT Trial, BetterLife’s Preclinical LSD Trial
Short-acting psychedelics biotech company ...
March 13, 2023 3:44 PM
In the first months of 2023, state-level psychedelics policy reform has been so constant that it is hard to view it as a passing trend. ...
March 13, 2023 9:30 AM
The Benzinga Psychedelics Capital Conference (PCC) is rapidly becoming the place to be for all those interested or involved in the space. In addition ...
March 10, 2023 11:49 AM
Clinical-stage biopharma company Mind Medicine (MindMed), Inc. (NASDAQ: MNMD) shared its financial results for the full year ended Dec. 31, 2022. ...
March 10, 2023 9:10 AM
The historical non-profit Multidisciplinary Association for Psychedelic Studies (MAPS) has announced the agenda and featured speakers of its ...
March 09, 2023 4:35 PM
The Healing Company (OTC: HLCO) and renowned integrative medicine specialist Dr. Deepak Chopra, MD. have become partners following a deal through ...
March 09, 2023 2:44 PM
The next-generation psychedelics R&D business is up and running, as BetterLife Pharma Inc. (OTCQB: BETRF)’s lead drug candidate LSD ana ...
March 09, 2023 12:17 PM
A Contract Research Organization (CRO) and a wholly-owned subsidiary of Wellbeing Digital Sciences Inc. (OTC: KONEF), KGK Science’s application ...
March 08, 2023 5:58 PM
This year’s edition of the Benzinga Psychedelics Capital Conference, THE place to be for those interested or already involved in the space, ...
March 08, 2023 5:00 PM
Senators Cory Booker (D-NJ), Rand Paul (R-KY) Reps Madeleine Dean (D-PA) and Nancy Mace (R-SC) filed a revised bill requesting an update on ...
March 08, 2023 10:01 AM
Short-acting psychedelics biotech company Small Pharma Inc. (OTCQB: DMTTF) shared positive outcomes from its Phase 2a study of SPL026, the first place ...
March 07, 2023 5:28 PM
The upcoming Psychedelics Capital Conference constitutes Benzinga’s effort to provide an exclusive opportunity to meet, connect with a ...
March 07, 2023 10:29 AM
Psychedelics Bills Around The Country: 9 New Proposals, Several Passes, Several Fails And A Successful Local Decriminalization
Throughout the 202 ...
March 06, 2023 9:21 PM
This year is the second edition of what is rapidly becoming the place to be for those interested in or already involved in the psychedelics ...
March 06, 2023 2:49 PM
The clinical-stage biopharma company atai Life Sciences (NASDAQ: ATAI) founded in 2018 shared updates on the two clinical trials as well as ...
March 06, 2023 1:14 PM
The exclusive sales partnership between psychedelics biotechs Mindset Pharma (OTCQB: MSSTF) and PharmAla Holdings resulted in the first sale of M ...
